健脾祛湿化瘀食疗方干预脾虚湿瘀型结直肠癌化疗相关性腹泻临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R247.1;R273

基金项目:

2022年广东省中医院中医药科学技术研究专项基金项目(YN2022HL03)


Clinical Study on Spleen-Fortifying,Dampness-Resolving and Stasis Dissolving Dietary Prescription for Intervention in Chemotherapy-Induced Diarrhea in Colorectal Cancer of Spleen Deficiency and Phlegm Blended with Blood Stasis Type
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察健脾祛湿化瘀食疗方干预脾虚湿瘀型结直肠癌化疗相关性腹泻(CID) 的临床疗效及 对患者功能状态的改善作用。方法:选取2023年3—12月在广东省中医院肿瘤科住院部接受术后化疗的脾虚湿 瘀型结直肠癌患者共66例。采用随机数字表法分为对照组和观察组,每组33例。对照组采用对症护理联合安 慰剂干预,观察组采用对症护理联合健脾祛湿化瘀食疗方干预。2组疗程均为10天。比较2组干预前后腹泻、 腹痛、粪便性状分级,Karnofsky评分(KPS评分),以及干预后腹泻、腹痛发生率。结果:干预后,观察组腹 泻、腹痛、粪便性状分级均较干预前改善,且均优于对照组,差异均有统计学意义(P<0.05);对照组腹泻、 腹痛、粪便性状分级与干预前比较,差异均无统计学意义(P>0.05)。干预后,观察组KPS评分较干预前升 高,且高于对照组,差异均有统计学意义(P<0.05)。干预后,观察组腹泻发生率46.88%(15/32),低于对照 组75.00% (24/32), 差异有统计学意义(P<0.05); 观察组腹痛发生率34.38% (11/32), 低于对照组 65.63%(21/32),差异有统计学意义(P<0.05)。结论:健脾祛湿化瘀食疗方可有效缓解脾虚湿瘀型结直肠癌 化疗患者的腹泻、腹痛症状,提高其功能状态。

    Abstract:

    Abstract: Objective: To observe the clinical efficacy of spleen-fortifying, dampness-resolving and stasis dissolving dietary prescription in intervening chemotherapy-induced diarrhea (CID) in colorectal cancer of spleen deficiency and phlegm blended with blood stasis type,and to explore its effect on improving patients' functional status. Methods:A total of 66 colorectal cancer patients of spleen deficiency and phlegm blended with blood stasis type who received postoperative chemotherapy in the Oncology Department of Guangdong Provincial Hospital of Chinese Medicine between March and December 2023 were selected. They were randomly divided into a control group and an observation group using a random number table method, with 33 cases in each group. The control group received symptomatic care combined with a placebo intervention, while the observation group received symptomatic care combined with the spleen-fortifying, dampness-resolving and stasis dissolving dietary prescription intervention. Both groups were treated for 10 days. Diarrhea, abdominal pain, stool consistency grading, Karnofsky Performance Status (KPS) score before and after the intervention,as well as the incidence of diarrhea and abdominal pain after the intervention were compared between the two groups. Results: After the intervention, the grading of diarrhea, abdominal pain,and stool consistency improved in the observation group compared to before the intervention and was superior to that in the control group,with differences being significant (P<0.05). In the control group,there were no significant differences in the grading of diarrhea, abdominal pain, and stool consistency compared to before the intervention( P>0.05). After the intervention,the KPS score in the observation group increased compared to before the intervention and was higher than that in the control group, with differences being significant (P<0.05). After the intervention, the incidence of diarrhea was 46.88% (15/32) in the observation group, which was lower than 75.00%( 24/32) in the control group,with the difference being significant( P<0.05). The incidence of abdominal pain was 34.38% (11/32) in the observation group, lower than that of 65.63% (21/32) in the control group, with the difference being significant (P<0.05). Conclusion:The spleen-fortifying,dampness-resolving and stasis dissolving dietary prescription can effectively alleviate diarrhea and abdominal pain, and improve the functional status of colorectal cancer patients undergoing chemotherapy of spleen deficiency and phlegm blended with blood stasis type.

    参考文献
    相似文献
    引证文献
引用本文

肖舒静,蔡姣芝,杨敏菲,成燕云.健脾祛湿化瘀食疗方干预脾虚湿瘀型结直肠癌化疗相关性腹泻临床研究[J].新中医,2026,58(8):141-146

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-04-29
  • 出版日期:
文章二维码